Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy

Publication

Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy

Journal Paper/Review - May 25, 2013

Bossi P, Siano Marco

Units

Medizinische Onkologie und Hämatologie

Contact

Marco Siano

Citation

Bossi P, Siano M. Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy. JCO Journal of Clinical Oncology 2013; 31

Type

Journal Paper/Review (Deutsch)

Journal

JCO Journal of Clinical Oncology 2013; 31

Publication Date

May 25, 2013

Brief description/objective

Bossi P, De Cecco L, Perrone F, Cortelazzi B, Cossu Rocca M, Siano M. Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy. J Clin Oncol 31, 2013 (suppl; abstr 6027)